Search Results

Skincare products in jars and bottles with pink lids are placed on a light surface with green leaves.
India

No Cosmetic Permitted to be Used as Injection: CDSCO

MBT Desk
2 min read
CDSCO has warned that cosmetic injections are illegal under the Drugs and Cosmetics Act, 1940, and Cosmetics Rules, 2020.
Illustration of different strips of tablets lying over a floor.
India

AstraZeneca Pharma India Secures CDSCO Nod for Expanded Use of Durvalumab in Cancer Treatment

MBT Desk
2 min read
Gastric cancer remains a major health challenge in India, ranking as the seventh most common cancer with over 64,000 new cases diagnosed annually
Colorful pills and capsules pink, blue, and orange spread out on a white surface.
Pharmacy

CDSCO Flags 167 Drug Samples as Substandard in December, Identifies 7 Spurious Medicines

MBT Desk
2 min read
Central Drugs Labs found 74 NSQ drug samples, while State Labs found 93.
An image of colourful tablets.
Pharmacy

CDSCO Labs Flag 205 Drug Samples as ‘Not of Standard Quality’ in November

MBT Desk
2 min read
Central Drugs Standard Control Organization flags quality lapses in routine surveillance, with NSQ and spurious medicines under investigation to protect patient safety.
Image of a hand wearing surgical gloves and holding an injection.
Pharmacy

CDSCO Mandates Phase I Trial for Mankind Pharma's Sintilimab Before Phase III Approval

Vanshika Kalra
2 min read
Regulators flag safety gaps and design flaws in Mankind Pharma’s proposed Phase III study of the PD-1 inhibitor.
The image shows a strip of tablet.
Pharmacy

CDSCO Moves to Curb Carcinogenic Impurity in Ranitidine; Manufacturers Told to Tighten NDMA Checks

MBT Desk
2 min read
CDSCO mandates batch-wise NDMA testing in ranitidine, urges expiry cuts, storage reviews, and launches expert study amid cancer risk concerns linked to the antacid's long-term safety.
Read More
logo
Medbound Times
www.medboundtimes.com